Pharmacological Treatment for Social Cognition: Current Evidence
| Autor: | Claudio Brasso, Cristiana Montemagni, Elisa Del Favero, Silvio Bellino, Cecilia Riccardi, Paola Rocca |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2021 |
| Předmět: |
Social Cognition
QH301-705.5 medicine.medical_treatment Review Catalysis Pharmacological treatment Inorganic Chemistry 03 medical and health sciences 0302 clinical medicine Cognition pharmacological treatment Social cognition medicine Animals Humans In patient Physical and Theoretical Chemistry Biology (General) Cognitive impairment Antipsychotic Molecular Biology QD1-999 Spectroscopy Standard treatment Organic Chemistry Schizophrenia Antipsychotic Agents General Medicine medicine.disease 030227 psychiatry Computer Science Applications antipsychotic schizophrenia Chemistry Psychology 030217 neurology & neurosurgery Clinical psychology |
| Zdroj: | International Journal of Molecular Sciences International Journal of Molecular Sciences, Vol 22, Iss 7457, p 7457 (2021) |
| ISSN: | 1422-0067 |
| Popis: | Cognitive impairment is currently considered a core feature of schizophrenia (SZ) and is gaining attention as a fundamental therapeutic target. Standard treatment for SZ involves the use of antipsychotics that are successfully used to control positive symptoms and disorganized behaviour. However, it is still unclear whether they are effective on social cognition (SC) impairment. Furthermore, different medications are currently being studied to improve SC in patients with SZ. A literature search on this topic was conducted using the PubMed database. All kinds of publications (i.e., reviews, original contributions and case reports) written in English and published in the last 15 years were included. The aim of our literature review is to draw a picture of the current state of the pharmacological treatment of SC impairment in SZ. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|